Publications

Sort by: Date | Author | Title

O'Connor, O. A., Bhagat, G., Ganapathi, K., Pedersen, M. B., D'Amore, F., Radeski, D. & Bates, S. E. (2014). Changing the paradigms of treatment in peripheral T-cell lymphoma: from biology to clinical practice. Clinical Cancer Research, 20(20), 5240-54. Article e006363. https://doi.org/10.1158/1078-0432.CCR-14-2020

Gisselbrecht, C., Borchmann, P., D'Amore, F., Illidge, T. M. & Zinzani, P. L. (2014). Challenging CD30-positive lymphomas--current challenges, new insights and future directions: joining a conversation on CD30+ lymphomas. Leukemia Research, 38(9), 1003. https://doi.org/10.1016/j.leukres.2014.08.013

Hybel, T. E., Vase, M. Ø., Lauridsen, K. L., Enemark, M. B., Møller, M. B., Pedersen, C., Pedersen, G., Hamilton-Dutoit, S., Obel, N., Schade Larsen, C., d’Amore, F. & Ludvigsen, M. (2022). CD38 is a potential treatment target in lymphoma patients concurrently infected with human immunodeficiency virus. Leukemia & Lymphoma, 63(6), 1479-1483. https://doi.org/10.1080/10428194.2021.2023741

Hölmich, L. R., Hamilton-Dutoit, S. J. & d’Amore, F. A. (2021). Brystimplantatassocieret anaplastisk storcellet lymfom. Ugeskrift for Læger, 183(11), Article V04210341.

Vonasek, J., Edslev, P. W., d'Amore, F. & Hasle, H. (2020). Brentuximab vedotin monotherapy is an effective treatment in a frail pediatric patient with Down syndrome and classical Hodgkin lymphoma. Pediatric Blood and Cancer, 67(2), Article e28082. https://doi.org/10.1002/pbc.28082

Vase, M. Ø., Friis, S., Bautz, A., Bendix, K., Sørensen, H. T. & d'Amore, F. (2013). Breast implants and anaplastic large cell lymphoma: A Danish population-based cohort study. Cancer Epidemiology, Biomarkers & Prevention, 22(11), 2126-2129. https://doi.org/10.1158/1055-9965.EPI-13-0633

Jørgensen, J., Kamper, P. & d'Amore, F. (2021). Behandling af maligne lymfomer. Ugeskrift for Læger, 183(42), Article V08210656.

Kim, S. J., Lim, J. Q., Laurensia, Y., Cho, J., Yoon, S. E., Lee, J. Y., Ryu, K. J., Ko, Y. H., Koh, Y., Cho, D., Lim, S. T., Beck Enemark, M., D'amore, F., Bjerre, M., Ong, C. K. & Kim, W. S. (2020). Avelumab for the treatment of relapsed or refractory extranodal NK/T-cell lymphoma: an open-label phase 2 study. Blood, 136(24), 2754-2763. https://doi.org/10.1182/blood.2020007247

Grønbæk, K. & d'Amore, F. A. (1995). Autoimmune phenomena in non-Hodgkin's lymphoma. Leukemia & Lymphoma, 18((3-4)), 311-16.

Snipsøyr, M. G., Ludvigsen, M., Petersen, E., Wiggers, H. & Honoré, B. (2016). A systematic review of biomarkers in the diagnosis of infective endocarditis. International Journal of Cardiology, 202, 564-570. https://doi.org/10.1016/j.ijcard.2015.09.028

d'Amore, F. A. & Wolthers, O. (1989). A study of cell-mediated immunity in type 1 diabetes using an antigen presentation assay. Diabetic Medicine, 6, 144-48.

Brincker, H. & d'Amore, F. A. (1995). A retrospective analysis of treatment outcome in 106 cases of localized gastric non-Hodgkin lymphomas. Danish Lymphoma Study Group, LYFO. Leukemia & Lymphoma, 18((3-4)), 281-8.

Ludvigsen, L. U. P., Andersen, A. S., Hamilton-Dutoit, S., Jensen-Fangel, S., Bøttger, P., Handberg, K. J., Ivarsen, P., d'Amore, F., Bibby, B. M., Albertsen, B. K., Jespersen, B. & Thomsen, M. K. (2023). A prospective evaluation of the diagnostic potential of EBV-DNA in plasma and whole blood. Journal of Clinical Virology, 167, Article 105579. https://doi.org/10.1016/j.jcv.2023.105579

Kim, S. J., Yoon, D. H., Jaccard, A., Chng, W. J., Lim, S. T., Hong, H., Park, Y., Chang, K. M., Maeda, Y., Ishida, F., Shin, D.-Y., Kim, J. S., Jeong, S. H., Yang, D.-H., Jo, J.-C., Lee, G.-W., Choi, C. W., Lee, W.-S., Chen, T.-Y. ... Kim, W. S. (2016). A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis. Lancet Oncology, 17(3), 389-400. https://doi.org/10.1016/S1470-2045(15)00533-1

Zinzani, P., Coiffier, B., Radford, J., Caballero, D., Fields, P., Chamuleau, M., D'Amore, F. A., Haioun, C., Thieblemont, C., Barca, E., Garcia, C., Johnson, PW., Van Imhoff, G., Saunders, A., Dwyer, K. & Morschhauser, F. (2014). A phase II open-label, multi-center study of anti-CCR4 monoclonal antibody mogamulizumab (KW-0761) in patients with previously treated peripheral t-cell lymphoma (PTCL). Blood, 124(21).

Urbonavicius, S., Srinanthalogen, R., Sandermann, J., Valius, M., Kaupinis, A. & Ludvigsen, M. (2024). A novel view to varicose veins pathogenesis: Proteomic profiling suggests a pivotal role of extracellular matrix degradation. Phlebology, 39(1), 20-28. https://doi.org/10.1177/02683555231206891

Gang, AO., Pedersen, M., D'Amore, F. A., Møller-Pedersen, L., Pedersen, BA., Jensen, P., Pedersen, BB., Møller, MB., Gadeberg, O. V., Ingeberg, S., Mourits-Andersen, T., Pulczynski, S., Klausen, TW. & Brown, P. D. N. (2012). A new simplified prognostic index with age cut-off of 70 years for patients with diffuse large B-cell lymphoma. A population-based analysis from the Danish Lymphoma Registry, LYFO. Blood, 120(21).

Pedersen, M., D'Amore, F. A., Pedersen, L. M., Jensen, B. A., Jensen, P., Pedersen, B. B., Møller, M. B., Gadeberg, O., Ingeberg, S., Mourits-Andersen, T., Pulczynski, S., Klausen, T. W. & Brown, P. D. N. (2012). A new simplified prognostic index with age cut-off of 70 years for patients with diffuse large B-cell lymphoma. A population-based analysis from the Danish Lymphoma Registry, LYFO. Abstract from 54th ASH Annual Meeting and Exposition, Atlanta, United States.

de Chadarevian, JP., Wolk, JH., Inniss, S., Lischner, HW., d'Amore, F. A., Faerber, EN. & Isaacson, GC. (1997). A newly recognized cause of wheezing:AIDS-related bronchial leiomyomas. Pediatric Pulmonology, 24((2)), 106-10.

Jepsen, J. R., d'Amore, F., Baandrup, U., Clausen, M. R., Gottschalck, E. & Aasted, B. (2009). Aleutian mink disease virus and humans. Emerging Infectious Diseases (Print Edition), 15(12), 2040-2. https://doi.org/10.3201/eid1512.090514

Wulf, G. G., Altmann, B., Ziepert, M., D’Amore, F., Held, G., Greil, R., Tournilhac, O., Relander, T., Viardot, A., Wilhelm, M., Wilhelm, C., Pezzutto, A., Zijlstra, J. M., Neste, E. V. D., Lugtenburg, P. J., Doorduijn, J. K., Gelder, M. V., van Imhoff, G. W., Zettl, F. ... ACT-2 study investigators (2021). Alemtuzumab plus CHOP versus CHOP in elderly patients with peripheral T-cell lymphoma: the DSHNHL2006-1B/ACT-2 trial. Leukemia, 35(1), 143-155. https://doi.org/10.1038/s41375-020-0838-5

Bech, M. R., Baumgartner-Nielsen, J., Peterslund, N. A., Steiniche, T., Deleuran, M. & d'Amore, F. (2013). Alemtuzumab is effective against severe chronic lymphocytic leukaemia-associated paraneoplastic pemphigus. British Journal of Dermatology, 169(2), 469-72. https://doi.org/10.1111/bjd.12324

Nielsen, R. B., Baumgartner-Nielsen, J., Peterslund, NA., Steiniche, T., Bang, K., Deleuran, M. & D'Amore, F. A. (2013). Alemtuzumab (ALZ) is effective against severe paraneoplastic pemphigus (PNP). British Journal of Dermatology.

Nielsen, R. B., Baumgartner-Nielsen, J., Peterslund, N. A., Steiniche, T., Deleuran, M. & D'Amore, F. A. (2013). Alemtuzumab (alz) is effective against severe chronic lymphocytic leukemia-associated paraneoplastic pemphigus (pnp). British Journal of Dermatology, 169(2).

Nielsen, R. B., Baumgartner-Nielsen, J., Peterslund, N. A., Steiniche, T., Bang, K., Deleuran, M. & D'Amore, F. A. (2013). Alemtuzumab (ALZ) is an effective treatment for both primary and relapsed severe paraneoplastic pemphigus (PNP) associated to B-cell chronic lymphocytic leukemia. British Journal of Dermatology, 169(2), 469-472.

Grant, C., Dunleavy, K., Janik, J. E., Shovlin, M., Steinberg, S. M., D'Amore, F. A., Pittaluga, S., Jaffe, E. & Wilson, W. H. (2012). Alemtuzumab (ALZ) in combination with Dose-Adjusted EPOC (DA-EPOCH) has higher efficacy in nodal than in extranodal or leukemic peripheral T-cell lymphoma. International Journal of Clinical Oncology.

Ludvigsen, M. (2007). Affinity purification and identification of ERC-55 interacting proteins: Master dissertation.

MacManus, M. P., Seymour, J. F., Tsang, H., Fisher, R., Keane, C., Sabdia, M. B., Law, S. C., Gunawardana, J., Nath, K., Kazakoff, S. H., Marques-Piubelli, M. L., Duenas, D. E., Green, M. R., Roos, D., O'Brien, P., McCann, A., Tsang, R., Davis, S., Christie, D. ... Tobin, J. W. D. (2024). Adjuvant rituximab and elevated intratumoural CD8 expression are associated with sustained disease control after radiotherapy in a randomised trial of systemic therapy in early-stage follicular lymphoma. EBioMedicine, 110, Article 105468. https://doi.org/10.1016/j.ebiom.2024.105468

Johnson, P., Federico, M., Kirkwood, A. A., Fossa, A., Berkahn, L., Carella, A., d'Amore, F., Enblad, G., Franceschetto, A., Fulham, M. J., Luminari, S., O'Doherty, M. J., Patrick, P., Roberts, T. H., Sidra, G., Stevens, L., Smith, P., Trotman, J., Viney, Z. N. ... Barrington, S. (2016). Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin's Lymphoma. The New England Journal of Medicine, 374(25), 2419-2429. https://doi.org/10.1056/NEJMoa1510093

Sørensen, J. F., Kristensen, D. T., Ørskov, A. D., Hansen, D. L., Aggerholm, A., Grønbæk, K., Roug, A. S. & Ludvigsen, M. (2025). A Danish nationwide population-based cohort study on acute myeloid leukemia with RUNX1::RUNX1T1 - Real-world outcomes and clinicopathological characteristics. Blood Cancer Journal, 15(1), Article 171. https://doi.org/10.1038/s41408-025-01377-8

Sobrero, A., Muzzulini, C., d'Amore, F. A., Bogliolo, G., Massa, G., Ghio, R. & Pannacciulli, I. (1982). Activity of 4'-epi-doxorubicin on normal hematopoietic precursor cells in mice. Cancer Treatment Report, 66(12), 2061-70.

Gang, A. O., Pedersen, M., d'Amore, F., Pedersen, L. M., Jensen, B. A., Jensen, P., Møller, M. B., Mourits-Andersen, H. T., Pedersen, R. S., Klausen, T. W. & de N Brown, P. (2015). A clinically based prognostic index for diffuse large B-cell lymphoma with a cut-off at 70 years of age significantly improves prognostic stratification: population-based analysis from the Danish Lymphoma Registry. Leukemia & Lymphoma, 56(9), 2556-2562. https://doi.org/10.3109/10428194.2015.1010078

Vase, M. Ø., Friis, S., Andrea, Sørensen, H. T. & D'Amore, F. A. (2011). Absence of anaplastic large cell lymphoma (ALCL) cases in a very large cohort of Danish women exposed to breast implants: results of a nationwide, population-based study. Blood, 118, 3689.

Christensen, M. S., Hansen, J., Ramlau-Hansen, C., Toft, G., d'Amore, F. & Kolstad, H. A. (2014). 0177 Exposure to styrene and the risk of cancer: a long-term follow-up study of workers in the Danish reinforced plastics industry. Occupational & Environmental Medicine, 71 Suppl 1, A82-3. https://doi.org/10.1136/oemed-2014-102362.257

Displaying results 251 to 284 out of 284

Revised 15.03.2021

Francesco Annibale d'Amore